Antioxidant, Anti-Inflammatory, Anti-Diabetic, and Pro-Osteogenic Activities of Polyphenols for the Treatment of Two Different Chronic Diseases: Type 2 Diabetes Mellitus and Osteoporosis.
Emanuele Salvatore ScarpaAntonella AntonelliGiancarlo BalerciaSofia SabatelliFilippo MaggiGiovanni CaprioliGilberta GiacchettiMatteo MicucciPublished in: Biomolecules (2024)
Polyphenols are natural bioactives occurring in medicinal and aromatic plants and food and beverages of plant origin. Compared with conventional therapies, plant-derived phytochemicals are more affordable and accessible and have no toxic side effects. Thus, pharmaceutical research is increasingly inclined to discover and study new and innovative natural molecules for the treatment of several chronic human diseases, like type 2 diabetes mellitus (T2DM) and osteoporosis. These pathological conditions are characterized by a chronic inflammatory state and persistent oxidative stress, which are interconnected and lead to the development and worsening of these two health disorders. Oral nano delivery strategies have been used to improve the bioavailability of polyphenols and to allow these natural molecules to exert their antioxidant, anti-inflammatory, anti-diabetic, and pro-osteogenic biological activities in in vivo experimental models and in patients. Polyphenols are commonly used in the formulations of nutraceuticals, which can counteract the detrimental effects of T2DM and osteoporosis pathologies. This review describes the polyphenols that can exert protective effects against T2DM and osteoporosis through the modulation of specific molecular markers and pathways. These bioactives could be used as adjuvants, in combination with synthetic drugs, in the future to develop innovative therapeutic strategies for the treatment of T2DM and osteoporosis.
Keyphrases
- anti inflammatory
- oxidative stress
- postmenopausal women
- bone mineral density
- end stage renal disease
- glycemic control
- healthcare
- type diabetes
- mesenchymal stem cells
- public health
- bone marrow
- chronic kidney disease
- endothelial cells
- metabolic syndrome
- newly diagnosed
- dna damage
- prognostic factors
- risk assessment
- ejection fraction
- climate change
- skeletal muscle
- human health
- drug induced
- cardiovascular risk factors
- heat shock
- health promotion
- heat stress
- induced pluripotent stem cells
- patient reported outcomes